Status:
TERMINATED
Using IVR to Maintain ACS Patients on Best Practice Guidelines
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Ottawa Heart Institute Research Corporation
Conditions:
Acute Coronary Syndrome
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether interactive voice response (IVR) technology can be used to bring post discharge care for acute coronary syndrome (ACS) closer to best practice guideli...
Detailed Description
Acute coronary syndrome (ACS) is a significant public-health problem in Canada and worldwide with 20,000 Canadians dying of myocardial infarction and 42,000 dying of coronary artery disease in 1999. L...
Eligibility Criteria
Inclusion
- Patients discharged from LHSC with ACS (acute myocardial infarction, STEMI, NSTEMI or unstable angina)
- Patients who have a land line telephone service at home
- Patients who speak English
Exclusion
- Patients discharged to a care facility or transferred to another health care institution
- Patients who cannot provide informed consent
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2014
Estimated Enrollment :
654 Patients enrolled
Trial Details
Trial ID
NCT01260207
Start Date
January 1 2010
End Date
December 15 2014
Last Update
August 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A 5A5